Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and Molecular dynamic Investigations of 7,8-Dihydroxyflavone Derivatives as Potential Neuroprotective Agents Against Alpha-synuclein.
Mohankumar T, Chandramohan V, Lalithamba HS, Jayaraj RL, Kumaradhas P, Sivanandam M, Hunday G, Vijayakumar R, Balakrishnan R, Manimaran D, Elangovan N. Mohankumar T, et al. Among authors: chandramohan v. Sci Rep. 2020 Jan 17;10(1):599. doi: 10.1038/s41598-020-57417-9. Sci Rep. 2020. PMID: 31953434 Free PMC article.
Author Correction: Design and Molecular dynamic Investigations of 7,8-Dihydroxyflavone Derivatives as Potential Neuroprotective Agents Against Alpha-synuclein.
Mohankumar T, Chandramohan V, Lalithamba HS, Jayaraj RL, Kumaradhas P, Sivanandam M, Hunday G, Vijayakumar R, Balakrishnan R, Manimaran D, Elangovan N. Mohankumar T, et al. Among authors: chandramohan v. Sci Rep. 2020 Mar 16;10(1):5085. doi: 10.1038/s41598-020-61862-x. Sci Rep. 2020. PMID: 32179853 Free PMC article.
In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy.
Gnanaraj C, Sekar M, Fuloria S, Swain SS, Gan SH, Chidambaram K, Rani NNIM, Balan T, Stephenie S, Lum PT, Jeyabalan S, Begum MY, Chandramohan V, Thangavelu L, Subramaniyan V, Fuloria NK. Gnanaraj C, et al. Among authors: chandramohan v. Molecules. 2022 Apr 29;27(9):2834. doi: 10.3390/molecules27092834. Molecules. 2022. PMID: 35566187 Free PMC article.
Bioactive phenolic fraction of Citrus maxima abate lipopolysaccharide-induced sickness behaviour and anorexia in mice: In-silico molecular docking and dynamic studies of biomarkers against NF-κB.
Nandeesh R, Vijayakumar S, Munnolli A, Alreddy A, Veerapur VP, Chandramohan V, Manjunatha E. Nandeesh R, et al. Among authors: chandramohan v. Biomed Pharmacother. 2018 Dec;108:1535-1545. doi: 10.1016/j.biopha.2018.10.004. Epub 2018 Oct 9. Biomed Pharmacother. 2018. PMID: 30372855 Free article.
Nephroprotective activity of Combretum micranthum G. Don in cisplatin induced nephrotoxicity in rats: In-vitro, in-vivo and in-silico experiments.
Kpemissi M, Eklu-Gadegbeku K, Veerapur VP, Negru M, Taulescu M, Chandramohan V, Hiriyan J, Banakar SM, Nv T, Suhas DS, Puneeth TA, Vijayakumar S, Metowogo K, Aklikokou K. Kpemissi M, et al. Among authors: chandramohan v. Biomed Pharmacother. 2019 Aug;116:108961. doi: 10.1016/j.biopha.2019.108961. Epub 2019 May 28. Biomed Pharmacother. 2019. PMID: 31146106 Free article.
Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor.
Pandian SRK, Pavadai P, Vellaisamy S, Ravishankar V, Palanisamy P, Sundar LM, Chandramohan V, Sankaranarayanan M, Panneerselvam T, Kunjiappan S. Pandian SRK, et al. Among authors: chandramohan v. Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):735-749. doi: 10.1007/s00210-020-02015-9. Epub 2020 Nov 6. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 33156389
73 results